HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognosis and clinical relevance of anisocoria-craniotomy latency for epidural hematoma in comatose patients.

AbstractOBJECTIVE:
To determine whether the time between onset of anisocoria and surgery for hematoma evacuation in the head-injured patient is a useful prognostic variable for outcome in the comatose patient with an acute epidural hematoma.
DESIGN:
Prospective.
MATERIALS AND METHODS:
Twenty-one patients with an acute traumatic epidural hematoma and an admission Glasgow Coma Scale score of less than 8 were analyzed.
RESULTS:
Anisocoria was present in 14 (67%) patients. Mortality rate was three times higher in this group than in the patients without anisocoria; however, this difference was not statistically significant (p = 0.21, Fisher's exact test). None of the patients with an anisocoria-craniotomy latency of 70 minutes or less died and all of these patients had a good or reasonable outcome. Analysis of the anisocoria-craniotomy latency in ten patients revealed that a lapse of more than 90 minutes was associated with a greater mortality compared with patients with a latency of less than 90 minutes (p = 0.0238, Fisher's exact test).
CONCLUSIONS:
In patients with an acute epidural hematoma, reducing the anisocoria-surgery interval below 90 minutes is significantly associated with a better outcome (p = 0.0238, Fisher's exact test).
AuthorsJ E Cohen, A Montero, Z H Israel
JournalThe Journal of trauma (J Trauma) Vol. 41 Issue 1 Pg. 120-2 (Jul 1996) ISSN: 0022-5282 [Print] United States
PMID8676403 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Anisocoria (etiology)
  • Craniocerebral Trauma (complications, mortality)
  • Craniotomy
  • Female
  • Hematoma, Epidural, Cranial (etiology, mortality, surgery)
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prospective Studies
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: